SRC and pancreatic neoplasm: In this review, we summarise and discuss the current understanding of the diverse and complex roles of aberrant Src signalling in the complex niche of a rapidly developing and metastasising pancreatic tumour, highlighting challenges with and new avenues for the utilisation of inhibitors that target this dynamic network.